NDP MPs Blake Desjarlais, Don Davies and Alexandre Boulerice react to Edmonton MP Randy Boissonnault resigning as Employment Minister amid allegations about his business dealings and criticism of shifting claims about his Indigenous ancestry.
But as frustration mounts over high prices — including a recent drive to boycott Loblaws — the NDP says the government should take action if the majority of MPs support such a move.
“An expression of the majority of people in the House of Commons I think should have a political, moral and ethical impact on any government that is serious about providing relief for people,” said NDP finance critic Don Davies.
The Mega Job Fair, recognized for bridging gaps between employers and potential employees, set a new precedent in fostering community and economic development within the region.
Don Davies, MP for Vancouver-Kingsway, praised the event, highlighting PICS’s instrumental role in community enrichment. “PICS has once again demonstrated its commitment to economic and community growth by successfully connecting aspiring individuals with potential employers,” Davies said, underlining the societal impact of such initiatives.
“This is a historic day for Canadians,” said NDP health critic and lead on pharmacare negotiations Don Davies Thursday morning.
“This is the culmination of a dream that began when Tommy Douglass invented health care in Saskatchewan in the 1940s. It’s the culmination of decades of hard work by New Democrats, progressive Canadians and allied organizations.”
“Every diabetic in this country, we want to make sure that they can get the insulin they need,” said NDP health critic Don Davies Wednesday.
“Every young woman who needs contraception, we want to make sure she can get the contraception she needs. These are the kinds of things that we’re working toward.”
The future of the NDP's supply-and-confidence deal with the Liberals could hinge on competing proposals for pharmacare legislation the parties exchanged over the weekend, NDP health critic Don Davies said Tuesday.
Davies said that one of the last issues still outstanding in the bipartisan negotiations on pharmacare has to do with who pays for the medication — private and public insurers or the federal government as the sole price negotiator and buyer.